Parkside Financial Bank & Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.4K | Buy |
179
+44
| +33% | +$14.3K | 0.01% | 848 |
|
|
2025
Q1 | $36.5K | Buy |
135
+79
| +141% | +$21.3K | ﹤0.01% | 937 |
|
|
2024
Q4 | $13.2K | Hold |
56
| – | – | ﹤0.01% | 1213 |
|
|
2024
Q3 | $15.4K | Buy |
56
+15
| +37% | +$4.13K | ﹤0.01% | 1128 |
|
|
2024
Q2 | $9.96K | Buy |
41
+5
| +14% | +$1.22K | ﹤0.01% | 1182 |
|
|
2024
Q1 | $5.38K | Sell |
36
-2
| -5% | -$299 | ﹤0.01% | 1325 |
|
|
2023
Q4 | $7.27K | Buy |
38
+13
| +52% | +$2.49K | ﹤0.01% | 1217 |
|
|
2023
Q3 | $4.43K | Buy |
25
+2
| +9% | +$354 | ﹤0.01% | 1411 |
|
|
2023
Q2 | $4.37K | Buy |
23
+3
| +15% | +$570 | ﹤0.01% | 1423 |
|
|
2023
Q1 | $4.01K | Sell |
20
-2
| -9% | -$401 | ﹤0.01% | 1449 |
|
|
2022
Q4 | $5.23K | Hold |
22
| – | – | ﹤0.01% | 1305 |
|
|
2022
Q3 | $5K | Buy |
22
+2
| +10% | +$455 | ﹤0.01% | 1189 |
|
|
2022
Q2 | $2K | Sell |
20
-11
| -35% | -$1.1K | ﹤0.01% | 1522 |
|
|
2022
Q1 | $5K | Sell |
31
-4
| -11% | -$645 | ﹤0.01% | 1269 |
|
|
2021
Q4 | $6K | Buy |
35
+4
| +13% | +$686 | ﹤0.01% | 1209 |
|
|
2021
Q3 | $6K | Buy |
31
+5
| +19% | +$968 | ﹤0.01% | 1141 |
|
|
2021
Q2 | $4K | Buy |
26
+6
| +30% | +$923 | ﹤0.01% | 1289 |
|
|
2021
Q1 | $3K | Hold |
20
| – | – | ﹤0.01% | 1340 |
|
|
2020
Q4 | $3K | Buy |
+20
| New | +$3K | ﹤0.01% | 1260 |
|
|
2019
Q4 | – | Sell |
-13
| Closed | -$1K | – | 1577 |
|
|
2019
Q3 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 1277 |
|
|
2016
Q1 | – | Sell |
-35
| Closed | -$3K | – | 1037 |
|
|
2015
Q4 | $3K | Sell |
35
-33
| -49% | -$2.83K | ﹤0.01% | 827 |
|
|
2015
Q3 | $5K | Buy |
+68
| New | +$5K | ﹤0.01% | 771 |
|